USP18 and neoplasm: Depletion of the negative regulator of type I IFN signaling USP18 in BMDMs or supplementation of IFN-β also decreased CD206 expression and scRNA-seq analyses underscored an anti-tumor polarization of macrophages due to USP18 deletion (85).